A Case of Thymoma-Myasthenia Gravis in an Adult Malaysian Patient with Anterior Mediastinal Lesion

Published on:February 2021
Indian Journal of Pharmacy Practice, 2021; 14(4):xx-xx
Case Report | doi:10.5530/ijopp.12.1.x

A Case of Thymoma-Myasthenia Gravis in an Adult Malaysian Patient with Anterior Mediastinal Lesion

Authors and affiliation (s):

Khaled Mohammed Alakhali*, Yasameen Mohammed Mahdi, Lyna Irawati, Abdulaleem Mahuob

Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur-56000, MALAYSIA.


Myasthenia gravis (MG) is a neuromuscular junction disease. Around fifteen percent of myasthenia gravis patients are found to have thymoma and twenty to twenty-five percent of thymoma patients have myasthenia gravis. T-MG is equally common of both men and women. It happens at any age, with a 50-year peak start. Asians, Pacific Islanders and African Americans have a greater chance of contracting this disease. Thymomatous myasthenia gravis tends to be clinically difficult; with poor prognosis. We reported a 58-year-old Chinese woman who wasadmitted to a public hospital with complaints of fever, tachycardia, nausea and chills. She has a history of MG and hyperlipidemia. In 2014, she had thymoma and underwent thymectomy. Five years later, she was diagnosed withrecurrent thymomastage IIIB and prescribed with combination chemotherapy of cyclophosphamide, doxorubicin and cisplatin. After receiving the first cycle of the chemotherapy regimen, she developed febrile neutropenia and thrombocytopenia. In conclusion, MG has a complicated clinical course and poor prognosis. Nevertheless, early aggressive treatment could improve the patient outcomes.

Key words: Myasthenia gravis, Thymoma, Thymectomy, Adult Patient, Malaysian.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs